Waiting
登录处理中...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 患者源性肿瘤外植体作为预测患者耐药性的"实时"临床前平台…
JoVE Journal
Cancer Research

需要订阅 JoVE 才能查看此 内容. 登录或开始免费试用。

JoVE Journal Cancer Research
患者源性肿瘤外植体作为预测患者耐药性的"实时"临床前平台
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Journal (Cancer Research)
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
A Method of Targeted Cell Isolation via Glass Surface Functionalization
Journal (Cancer Research)
A Method of Targeted Cell Isolation via Glass Surface Functionalization
 
Click here for the English version

患者源性肿瘤外植体作为预测患者耐药性的"实时"临床前平台

Article DOI: 10.3791/62130-v • 07:42 min • February 7th, 2021
February 7th, 2021 •
1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1
1Leicester Cancer Research Center, University of Leicester, 2MRC Toxicology Unit

章节

总结概括
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

本文描述了在实时的、与患者相关的临床前模型系统中评估肿瘤药物反应的患者来源的外植体的生成、药物治疗和分析方法。

Tags

癌症研究，第168期，外植体，肿瘤，临床前模型，组织学，数字病理学，多免疫荧光
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter